Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: the OCEAN study.
Eastell, Richard
Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: the OCEAN study. [electronic resource] - Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research Jun 2011 - 1303-12 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1523-4681
10.1002/jbmr.341 doi
Biomarkers--blood
Bone Density--drug effects
Bone Remodeling--drug effects
Cathepsin K--antagonists & inhibitors
Demography
Enzyme Inhibitors--adverse effects
Female
Humans
Osteoporosis, Postmenopausal--blood
Thiazolidines--adverse effects
Treatment Outcome
Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: the OCEAN study. [electronic resource] - Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research Jun 2011 - 1303-12 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1523-4681
10.1002/jbmr.341 doi
Biomarkers--blood
Bone Density--drug effects
Bone Remodeling--drug effects
Cathepsin K--antagonists & inhibitors
Demography
Enzyme Inhibitors--adverse effects
Female
Humans
Osteoporosis, Postmenopausal--blood
Thiazolidines--adverse effects
Treatment Outcome